China
0
Xinxing Road, Lushan Industrial Zone Pingdingshan Henan China
Add Favorite
Report Supplier
Business Description
Shengguang Medical Instrument Co., Ltd, established in 2000, we are a professional manufacturer designated by State Food and Drug Administration to produce disposable medical instruments. Our company produces all kinds of disposable syringes and infusion sets, with more than 10,000 workers, including 900 engineering technicians and 300 technicians holding the internal examination qualification certificate issued by the State. Our disposable infusion sets, sterile syringes, blood transfusion sets and their fitting parts passed ISO9001:2000 quality control system, ISO13485:2003 quality control system and CE certifications. Our products are in conformity with GMP standard and advanced testing standards. We have two factories in Pingdingshan City. Our production capacity is 8,000,000 pieces of disposable syringes and 3,000,000 sets of infusion sets per day. Our leading products are: Disposable infusion sets, Disposable syringe, Sterile syringes, Blood transfusion set Wheelchair scalp vein needle disposable isolation gown, Surgical Gown, Disposable face mask, kinds of nurse cap, shoe cover and other ODM nonwoven products. anticipating cooperation with any serious customer worldwide.
Business Overview
Avg Response Time
≤ 1h
Export Capabilities
Declared by supplierJoinkona Medical Products Co.,Ltd has been exporting since 2000.
Export start year
2000
Trade Capabilities
Business Terms
Trade Ability
Non Woven Face Mask market insight
As of 18 November 2026, 9 suppliers in 6 countries offer 9 active supply listings on Freshdi across Medical & HealthCare, the group Non Woven Face Mask belongs to. Suppliers across Medical & HealthCare, the wider group Non Woven Face Mask belongs to, come from 6 countries, led by India at 22.2%, on Freshdi as of 18 November 2026. Buyer inquiry volume across Medical & HealthCare, the wider group Non Woven Face Mask belongs to, rose 100% on Freshdi in the 30 days to 18 November 2026 against the 30 days before, with 103.41% volatility in monthly inquiry and quotation activity over 338 days.
